NBC News @NBCNews
The FDA has withdrawn emergency use authorization for AstraZeneca’s Covid-19 antibody drug Evusheld, as the treatment is not expected to neutralize the currently dominant subvariant of omicron. https://t.co/rEOjj46Fek — PolitiTweet.org